HighMark Wealth Management LLC CNTA CENTESSA PHARMACEUTICALS PLC

Ownership history in HighMark Wealth Management LLC  ·  8 quarters on record

AI Ownership Summary

HighMark Wealth Management LLC reported CENTESSA PHARMACEUTICALS PLC (CNTA) in 8 quarterly 13F filings from 2024 Q2 through 2026 Q1. Peak portfolio weight reached 3.83% in 2026 Q1. The latest visible filing shows CNTA at 3.83% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CNTA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was HighMark Wealth Management LLC's position in CENTESSA PHARMACEUTICALS PLC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CNTA was reported at 3.83% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
3.83% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How HighMark Wealth Management LLC held CNTA — position size vs. price
% of Fund (quarterly)    CNTA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED 236,785 0% 3.83% $9.4M 2026-05-06 $39.60
2025 Q4 REDUCED 236,785 -500 -0.2% 2.41% $5.9M 2026-02-05 $23.54
2025 Q3 UNCHANGED 237,285 0% 2.53% $5.8M 2025-10-20 $22.79
2025 Q2 ADDED 237,285 +1,500 +0.6% 1.52% $3.1M 2025-07-21 $16.06
2025 Q1 ADDED 235,785 +69,650 +41.9% 2.00% $3.4M 2025-04-24 $13.61
2024 Q4 REDUCED 166,135 -1,000 -0.6% 1.60% $2.8M 2025-01-31 $16.92
2024 Q3 ADDED 167,135 +74,135 +79.7% 1.46% $2.7M 2024-10-17 $15.81
2024 Q2 INITIATED 93,000 0.51% $840K 2024-07-29 $10.65

FAQ About HighMark Wealth Management LLC and CNTA

These are the practical questions this page is built to answer before you even open the full history table.

How long has HighMark Wealth Management LLC reported owning CNTA?

HighMark Wealth Management LLC reported CNTA across 8 quarterly 13F filings, from 2024 Q2 through 2026 Q1.

What was the largest reported CNTA position in HighMark Wealth Management LLC's portfolio?

The largest reported portfolio weight for CNTA was 3.83% in 2026 Q1.

What is the latest reported CNTA position on this page?

The most recent filing on this page is 2026 Q1, when HighMark Wealth Management LLC reported 236,785 shares, equal to 3.83% of portfolio, with an estimated market value of $9.4M.

What does the chart on this CNTA ownership page compare?

The chart compares HighMark Wealth Management LLC's quarterly CNTA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did HighMark Wealth Management LLC time their CNTA position?

Based on 13F filing dates vs. subsequent CNTA price moves, HighMark Wealth Management LLC correctly timed 5 out of 6 reported position changes (83%). The annualised alpha on CNTA relative to SPY over the holding period was +75.5%.

← Back to HighMark Wealth Management LLC Holdings